Clinical trial Recruiting at 1 site Interventional Ages 18 to 40 Women only

Monitoring glucose levels in infertile women undergoing assisted reproduction

Official title: Glucose Pattern in Infertile Women Receiving Assisted Reproduction: a Prospective Study Using Continuous Glucose Monitoring

Run by Shanghai 6th People's Hospital · NCT06863337 · Data updated 2026-11-12

This study is testing if keeping track of blood sugar levels in women undergoing fertility treatments like IVF can help improve their chances of getting pregnant and having a healthy baby.

More Infertility, Female trials

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexWomen only
Enrollment100 (estimated)
SponsorShanghai 6th People's Hospital
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedMarch 26, 2025
Main results expectedJune 30, 2026
Study endsApril 30, 2027
Registry record updatedDecember 23, 2025
Trial IDNCT06863337 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are infertile women aged 18 to 40 who are undergoing their first or second IVF/ICSI cycle.

Probably not a fit

Patients with recent infections, glucocorticoid treatment, or specific clinical conditions affecting ART outcomes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to continuously monitor glucose variations in infertile women receiving assisted reproductive technologies (ART) such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). By utilizing continuous glucose monitoring (CGM), the research seeks to explore the relationship between glucose fluctuations and ART outcomes, potentially leading to improved clinical pregnancy and live birth rates. The findings may help tailor ART regimens to minimize glucose variation, enhancing individualized patient care. This approach is novel as glucose monitoring is not typically performed during ART cycles.

Why it matters

Potential benefit: If successful, this study could lead to improved pregnancy and live birth rates for women undergoing assisted reproduction.

How similar studies have gone: While this approach of continuous glucose monitoring during ART is novel, similar studies in other contexts have shown promise in optimizing treatment outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Informed consent and voluntary participation in this study;
2. Age ≥ 18 years and ≤40 years old;
3. Infertile patients who will undergo their first or second cycle of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) at the study center;
4. The chosen ovulation promotion regimens is the GnRH antagonist regimen/progesterone-promoting ovulation under hyperprogesterone state (PPOS) regimen.

Exclusion Criteria:

1. Recent infections (excluding viral infections of the reproductive system such as HPV);
2. Recent glucocorticoid treatment or chemotherapy;
3. Clinical conditions affecting the outcome of assisted reproduction, including repeated implantation failure, recurrent spontaneous abortion, history of unilateral oophorectomy, uterine malformations, and parental karyotype abnormalities;
4. Participants were unable to tolerate tape adhesive around sensor placement area, or with medically documented allergy towards the adhesive (glue) of plasters, or with serious skin diseases (e.g. psoriasis vulgaris, bacterial skin diseases) around sensor placement area.

Where it's running

  • Shanghai Sixth People's Hospital
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.